Issued on:30/03/2020 - 05:34Modified:30/03/2020 - 05:32
Washington (AFP)
A limited emergency-use authorization for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients.
In a statement published Sunday, the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile -- including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments.
https://www.france24.com/en/20200330-us-regulator-approves-limited-use-of-malaria-drugs-for-virus
These two drugs has been used by the Chinese, Korean, Japanese, the European, even ours and the US as a treatment for a few months now.
The Chinese, the Korean and Japanese should have some feedback in April, from their large clinical trials on these two drugs.
If its effective, then lockdown will be relaxed.
